Literature DB >> 31642895

Quantitative assessment of effective regurgitant orifice: impact on risk stratification, and cut-off for severe and torrential tricuspid regurgitation grade.

Yogev Peri1, Ben Sadeh1, Chen Sherez1, Aviram Hochstadt1, Simon Biner1, Galit Aviram2, Meirav Ingbir1, Ido Nachmany3, Guy Topaz4, Nir Flint1, Gad Keren1, Yan Topilsky1.   

Abstract

AIMS: Asses the added value of quantitative evaluation of tricuspid regurgitation (TR), the proper cut-off value for severe TR and 'torrential TR' based on outcome data. The added value of quantitative evaluation of TR, and the cut-off values associated with increased mortality are unknown. METHODS AND
RESULTS: In patients with all-cause TR assessed both qualitatively and quantitatively by proximal iso-velocity surface area method, long-term and 1-year outcome analysis was conducted. Thresholds for excess mortality were assessed using spline curves, receiver-operating characteristic curves, and minimum P-value analysis. The study involved 676 patients with all-cause TR (age 73.9 ± 14 years, male 45%, ejection fraction 52.9 ± 14%). Effective regurgitant orifice (ERO) was strongly associated with decreased survival in unadjusted [hazard ratio (HR) 2.38 (1.79-3.01), P < 0.0001 per 0.1 cm2 increment] and adjusted [2.6 (1.25-5.0), P = 0.01] analyses. Quantitative grading was superior to qualitative grading in prediction of outcome (P < 0.01). The optimal cut-off value for the best separation in survival between groups of patients with severe vs. lesser degree of TR was 0.35 cm2 [P < 0.0001, HR =2.0 (1.5-2.7)]. ERO negatively impacted survival, even when including only the subgroup of patients with severe TR [HR 1.5 (1.01-2.3); P = 0.04]. The optimal threshold corresponding for the best separation for survival between groups of patients with severe vs. 'torrential' TR was 0.7 cm2 [P = 0.005, HR =2.6 (1.2-5.1)].
CONCLUSION: TR can be severe and even 'torrential' and is associated with excess mortality. Quantitative assessment of TR by ERO measurement is a powerful independent predictor of outcome, superior to standard qualitative assessment. The optimal cut-off above which mortality is increased is 0.35 cm2, similar albeit slightly lower than suggested in recent guidelines. Torrential TR >0.7 cm2 is associated with poorer survival compared to patients with severe TR (ERO > 0.4 cm2 and <0.7 cm2). Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  effective regurgitant orifice (ERO); regurgitant volume (RVol); tricuspid regurgitation (TR)

Mesh:

Year:  2020        PMID: 31642895     DOI: 10.1093/ehjci/jez267

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  7 in total

Review 1.  Sex Differences and Similarities in Valvular Heart Disease.

Authors:  Jacqueline T DesJardin; Joanna Chikwe; Rebecca T Hahn; Judy W Hung; Francesca N Delling
Journal:  Circ Res       Date:  2022-02-17       Impact factor: 17.367

Review 2.  Imaging and Patient Selection for Transcatheter Tricuspid Valve Interventions.

Authors:  Mirjam G Winkel; Nicolas Brugger; Omar K Khalique; Christoph Gräni; Adrian Huber; Thomas Pilgrim; Michael Billinger; Stephan Windecker; Rebecca T Hahn; Fabien Praz
Journal:  Front Cardiovasc Med       Date:  2020-05-05

Review 3.  Multi-Modality Imaging for Interventions in Tricuspid Valve Disease.

Authors:  Federico Fortuni; Kensuke Hirasawa; Jeroen J Bax; Victoria Delgado; Nina Ajmone Marsan
Journal:  Front Cardiovasc Med       Date:  2021-02-09

4.  Determinants of Morbidity and Mortality Associated With Isolated Tricuspid Valve Surgery.

Authors:  Akram Kawsara; Fahad Alqahtani; Vuyisile T Nkomo; Mackram F Eleid; Sorin V Pislaru; Charanjit S Rihal; Rick A Nishimura; Hartzell V Schaff; Juan A Crestanello; Mohamad Alkhouli
Journal:  J Am Heart Assoc       Date:  2021-01-05       Impact factor: 5.501

5.  Prevalence and Prognostic Importance of Massive Tricuspid Regurgitation in Patients Undergoing Tricuspid Annuloplasty With Concomitant Left-Sided Valve Surgery: A Study on Rheumatic Valvular Heart Disease.

Authors:  Yan Chen; Yap-Hang Chan; Mei-Zhen Wu; Yu-Juan Yu; Yui-Ming Lam; Ko-Yung Sit; Daniel Tai-Leung Chan; Cally Ka-Lai Ho; Lai-Ming Ho; Chu-Pak Lau; Wing-Kuk Au; Hung-Fat Tse; Kai-Hang Yiu
Journal:  Front Cardiovasc Med       Date:  2022-01-27

Review 6.  Atrial Functional Tricuspid Regurgitation as a Distinct Pathophysiological and Clinical Entity: No Idiopathic Tricuspid Regurgitation Anymore.

Authors:  Diana R Florescu; Denisa Muraru; Valentina Volpato; Mara Gavazzoni; Sergio Caravita; Michele Tomaselli; Pellegrino Ciampi; Cristina Florescu; Tudor A Bălșeanu; Gianfranco Parati; Luigi P Badano
Journal:  J Clin Med       Date:  2022-01-13       Impact factor: 4.241

Review 7.  State-of-the-art intra-procedural imaging for the mitral and tricuspid PASCAL Repair System.

Authors:  Rebecca T Hahn; Susheel K Kodali
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2022-02-22       Impact factor: 6.875

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.